Yahoo Web Search

Search results

    • Q1 2024 Acumen Pharmaceuticals Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 hours ago

      We are also on track to initiate a Phase 1 study in healthy subjects for a subcutaneous formulation of sabirnetug in mid-2024. We believe a competitive product profile for sabirnetug includes ...

    • Q1 2024 CV Sciences Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 hours ago

      We are also supporting our EU team in expanding sales in the EU and other non US markets. Our most recent transaction of Elevated Softgels provides us with operational flexibility< ...